Dr. Bucshon Opposes House Democrats’ Soviet-Style Drug Pricing Legislation
A Government Takeover that will Lead to Fewer Cures and Lost Hope for Americans
“No one disagrees that the cost of prescription drugs are too high and we need to work to make them affordable for American families. We have a historic opportunity for Republicans and Democrats in Congress to work together to pass meaningful reforms that would get drug costs down. However, while Americans must continue making difficult choices in order to afford their prescription drugs, Speaker Pelosi has chosen to put politics over progress by jamming partisan legislation through the House that will lead to fewer cures for patients—not lower prices.
“If H.R. 3 – which is dead on arrival in the United States Senate and President Trump has said he will veto – were somehow to become law, we know this legislation will lead to fewer cures and treatments. Estimates show that anywhere from 8 to more than 100 new cures and treatments will be lost in the next decade alone. These are drugs that could cure Alzheimer’s, ALS, or even cancer. While House Democrats may believe that preventing these cures and treatments from coming to market is ‘worth it,’ I do not. As a physician, the thought of patients being denied access to a potentially life-saving cure or treatment because of this partisan legislation is not a risk I am willing to take, and it is not a risk the American people should have to suffer. Simply put, a government takeover of the drug industry will lead to fewer cures and lost hope for Americans.
“If Speaker Pelosi and House Democrats were serious about lowering drug prices, then they should have worked with House Republicans to pass legislation that can actually be signed into law. House Republicans are serious about lowering drug costs, and that is why I supported the Lower Costs, More Cures Act (H.R. 19), which is legislation comprised of positive solutions that have bipartisan support that we know can help reduce the cost of prescription drugs by lowering out of pocket spending, protecting access to new and innovative cures, increasing transparency, and championing competition.”
Lower Drug Costs Now Act of 2019 (H.R. 3)
Lower Costs, More Cures Act (H.R. 19)
- Washington, DC Office
- Evansville Office
610 Main Street
First Floor Small Conference Room
Jasper, IN 47547 Hours: 1st & 3rd Tuesday of each month from 10:00am – 1:00pm Eastern Time
- Terre Haute Office
1500 N. Chestnut Street
Vincennes, IN 47591 Hours: 1st & 3rd Wednesday of each month from 10:00am – 12:00pm Eastern Time